# An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants

> **NCT00760669** · — · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 1061 (actual)

## Conditions studied

- Spondylitis, Ankylosing
- Arthritis, Rheumatoid
- Psoriasis
- Arthritis, Psoriatic

## Interventions

- **DRUG:** Infliximab; observational study
- **DRUG:** Methotrexate; observational study

## Key facts

- **NCT ID:** NCT00760669
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 1061 (ACTUAL)
- **Last updated:** 2013-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760669, "An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00760669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*